One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true...
/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20chart%20-by%20IgorGolovniov%20via%20Shutterstock.jpg)
IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.
Sophie V. Vandebroek, a director at $IDXX ($IDXX), sold 344 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.5% of their...
/Idexx%20Laboratories%2C%20Inc_%20outside%20lab-by%20Sundry%20Photography%20via%20iStock.jpg)
Despite IDEXX Laboratories’ underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today.
IDEXX Laboratories is scheduled to release its fiscal third-quarter earnings this month, and analysts project a single-digit profit growth.
Investors in IDEXX Laboratories, Inc.IDXX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $210.00 Call had some of the highest implied...
/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20logo-%20by%20T_Schneider%20via%20Shutterstock.jpg)
IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.